Concurrently, NrasG12D, in conjunction with heterozygous Dnmt3a loss, promotes AML onset in one-third of the induced mice, providing a potentially more biologically pertinent representation given the prevalent heterozygosity of DNMT3A mutations in human disease. The gene discussed is DNMT3A; the disease is acute myeloid leukemia.